Toxoplasmosis in Cats: Zoonotic Risks and Prevention During Pregnancy

Etiology and Life Cycle

Toxoplasmosis is caused by the obligate intracellular apicomplexan parasite Toxoplasma gondii. The definitive host is the domestic cat and other felids, in which the parasite completes its sexual cycle in the intestinal epithelium [1]. The asexual cycle occurs in a wide range of intermediate hosts, including mammals and birds [2]. The life cycle involves three infectious stages: tachyzoites (rapidly dividing), bradyzoites (slowly dividing within tissue cysts), and sporozoites (within sporulated oocysts) [3]. Cats become infected by ingesting tissue cysts from intermediate hosts or, less commonly, by ingesting sporulated oocysts from the environment [4]. After ingestion, bradyzoites are released and invade enterocytes, initiating the entero-epithelial cycle that culminates in the production of unsporulated oocysts [1]. A single cat can shed millions of oocysts over a period of one to three weeks [5]. Oocysts sporulate in the environment within one to five days, becoming infectious to intermediate hosts and humans [6]. The pre-sexual stages of T. gondii in the feline gut have been characterized at the single-cell level, revealing a complex proliferative process that precedes gametogenesis [3, 1]. MicroRNA expression in the feline small intestine is dynamically regulated during infection, reflecting host-parasite interactions at the mucosal interface [7].

Epidemiology

T. gondii infection is distributed globally, with seroprevalence rates varying widely by geographic region, host species, and management practices [8, 4]. In domestic cats, seroprevalence rates range from less than 10% to over 60% depending on the population studied [8, 4]. A study in Hong Kong reported a seroprevalence of 37.5% in privately-owned cats and 47.2% in community cats [8]. In Jordan, a seroprevalence of 41.3% was detected in stray and owned cats, with molecular detection of T. gondii DNA in 18.5% of fecal samples [4]. Stray cats in Bangkok, Thailand, showed a 12.5% PCR positivity rate in fecal samples [5]. Seroprevalence in other animal species also reflects environmental contamination. Goats in Nigeria showed a 34.7% seroprevalence [2], dairy cattle in Turkey had a 23.1% seroprevalence [9], and dogs in the Brazilian Pantanal region had a 72.5% seroprevalence [10]. Deer in Iraq exhibited a 15.2% seroprevalence [11]. These data indicate widespread environmental oocyst contamination [6, 12]. Risk factors for feline infection include outdoor access, hunting behavior, raw meat consumption, and stray or feral status [8, 4]. In pigs from eastern Spain, low seroprevalence (2.1%) was associated with intensive farming and controlled animal entry [13]. Social marginalization and environmental degradation in urban informal settlements have been linked to higher T. gondii exposure in humans, highlighting the role of environmental contamination [6].

Clinical Signs in Cats

Most feline T. gondii infections are subclinical [14]. Clinical disease occurs primarily in immunocompromised cats or in kittens following transplacental or transmammary transmission [15]. The most common clinical manifestations include fever, lethargy, anorexia, and lymphadenopathy [14]. Ocular toxoplasmosis presents as uveitis, chorioretinitis, or anterior chamber inflammation [16]. Neurological signs, including seizures, ataxia, and behavioral changes, result from encephalitis or meningoencephalitis [17]. Respiratory signs such as dyspnea and cough can occur due to pneumonitis. Hepatic and pancreatic involvement may cause icterus and vomiting. A study of 72 cats with pyogranulomatous and neutrophilic lymphadenitis identified toxoplasmosis as a differential diagnosis in a subset of cases [14]. The parasite can also be detected in reproductive tissues of cats from neutering programs, suggesting potential vertical transmission [15].

Pathology

The pathological hallmark of acute toxoplasmosis is multifocal necrosis in affected organs, including the liver, lungs, lymph nodes, and central nervous system [18]. Tachyzoites are observed within necrotic foci, often accompanied by a mixed inflammatory infiltrate of neutrophils, macrophages, and lymphocytes [14]. Chronic infection is characterized by the presence of tissue cysts (containing bradyzoites) in the brain, skeletal muscle, and myocardium, with minimal associated inflammation [18]. In the feline intestinal tract, the sexual stages cause enterocyte damage and villous blunting during the entero-epithelial phase [1]. In aborted fetuses, T. gondii can be detected in the myocardium and brain, confirming transplacental transmission [19, 20]. Histopathological examination of aborted goat fetuses in Algeria revealed myocarditis and encephalitis with intralesional tachyzoites [20]. Similarly, an aborted equine fetus in Brazil showed molecular evidence of T. gondii in multiple tissues [19].

Diagnostics

Diagnosis of feline toxoplasmosis relies on a combination of serological, molecular, and histopathological methods.

Serological Methods

Serological detection of anti-T. gondii antibodies (IgG and IgM) is the most common diagnostic approach [21, 8]. Commercial ELISA kits are widely used for screening [22]. A double-antigen sandwich colloidal gold immunochromatographic strip has been developed for multi-species antibody detection, including cats, providing a rapid point-of-care option [22]. A SAG1-based colloidal gold immunochromatographic strip has also been validated for swine and shows potential for cross-species application [23]. The MIC17A antigen has been evaluated as a marker for both entero-epithelial and chronic stage infection in cats [24]. Seroprevalence studies in veterinary professionals and students in Mexico revealed a 14.6% seropositivity rate, indicating occupational exposure risk [21].

Molecular Methods

PCR-based assays detect T. gondii DNA in blood, tissue, or fecal samples [5, 25]. An antisense PCR assay has been developed specifically for detection in domestic cats, demonstrating high sensitivity and specificity [25]. Conventional PCR targeting the B1 gene or 529 bp repeat element is commonly used [5, 4]. Real-time quantitative PCR allows for parasite load quantification. PCR detection in fecal samples is challenging due to low oocyst numbers and PCR inhibitors, but it remains useful for identifying actively shedding cats [5].

Histopathology and Cytology

Histopathological examination of biopsy or necropsy tissues can reveal tachyzoites or tissue cysts [20]. Immunohistochemistry using anti-T. gondii antibodies enhances detection sensitivity. Cytological examination of cerebrospinal fluid, bronchoalveolar lavage fluid, or lymph node aspirates may identify tachyzoites in acute cases [14].

Diagnostic Algorithm

flowchart TD
    A[Clinical suspicion of feline toxoplasmosis], > B{Serological testing}
    B, > C[IgG positive, IgM negative]
    B, > D[IgG positive, IgM positive]
    B, > E[IgG negative, IgM negative]
    C, > F[Chronic infection; no active shedding likely]
    D, > G[Acute or reactivated infection]
    G, > H{Confirm with PCR}
    H, > I[PCR positive: active infection]
    H, > J[PCR negative: possible early infection]
    E, > K[No prior exposure; repeat serology in 2-4 weeks]
    K, > L[Seroconversion: acute infection]
    K, > M[No seroconversion: no infection]
    I, > N[Consider treatment and oocyst shedding precautions]
    F, > O[No treatment indicated; monitor for reactivation]

Treatment

Treatment of clinical feline toxoplasmosis is indicated in cases of active disease, particularly with ocular, neurological, or systemic signs [14]. The standard therapeutic regimen includes clindamycin (10-12 mg/kg orally every 12 hours for 2-4 weeks) or a combination of pyrimethamine and a sulfonamide. Clindamycin is the most commonly used drug in cats due to its efficacy and safety profile. Supportive care, including fluid therapy and nutritional support, is essential in severe cases. Treatment does not eliminate tissue cysts, and recrudescence can occur if the cat becomes immunocompromised. Gene-edited live-attenuated vaccines are under development and show promise for preventing infection and reducing oocyst shedding in cats [26, 27]. Advances in mRNA vaccine technology and antigen discovery are being explored within a One Health framework [27].

Zoonotic Risks and Cat Toxoplasmosis Baby

The primary zoonotic risk from cats is the ingestion of sporulated oocysts shed in feline feces [6, 28]. Oocysts can contaminate soil, water, and food, leading to infection in humans and other animals [6, 2]. Direct contact with cats is not considered a major risk factor for human infection, as cats typically shed oocysts for only a short period and oocysts require sporulation to become infectious [28]. However, handling of contaminated litter boxes, gardening in contaminated soil, or consumption of unwashed vegetables can lead to infection [29, 30]. The term "cat toxoplasmosis baby" refers to the risk of congenital toxoplasmosis when a pregnant woman acquires a primary T. gondii infection during gestation [31, 29]. Congenital transmission can result in fetal death, stillbirth, or neonatal disease, including chorioretinitis, intracranial calcifications, and hydrocephalus [31, 20]. A study in Turkey found a significant association between anti-T. gondii antibody seropositivity and a history of abortion or stillbirth [31]. In Côte d'Ivoire, knowledge and practices regarding toxoplasmosis prevention among pregnant women were found to be inadequate, highlighting the need for targeted education [29]. University students in Iraq also demonstrated limited knowledge of toxoplasmosis transmission routes [30]. The risk of congenital toxoplasmosis is highest when primary infection occurs in the third trimester, although the severity of fetal disease is greatest with first-trimester infection [31]. Serological screening of pregnant women for T. gondii antibodies is standard practice in some countries [28]. Women who are seronegative should receive counseling on preventive measures [28].

Prevention During Pregnancy

Prevention of zoonotic transmission from cats to pregnant women focuses on reducing exposure to oocysts [28]. Key recommendations include:

• Pregnant women should avoid cleaning litter boxes. If unavoidable, disposable gloves should be worn and hands washed thoroughly afterward.
• Litter boxes should be cleaned daily, as oocysts require 1-5 days to sporulate and become infectious.
• Cats should be kept indoors to prevent hunting and ingestion of intermediate hosts.
• Cats should not be fed raw or undercooked meat.
• Pregnant women should wear gloves when gardening and wash hands after contact with soil.
• All fruits and vegetables should be washed thoroughly before consumption.
• Meat should be cooked to an internal temperature of at least 67 degrees Celsius to kill tissue cysts.

These measures are supported by seroepidemiological studies showing that ownership of a cat is not an independent risk factor for human infection when proper hygiene practices are followed [28]. The AB blood group system phenotype in cats does not play a role in T. gondii infection susceptibility [32]. Behavioral changes in infected intermediate hosts, including rodents, have been described, but the relevance of such changes to direct cat-to-human transmission is minimal [17].

Control and One Health Implications

Control of T. gondii requires a One Health approach integrating veterinary, environmental, and public health measures [27]. In cats, preventing access to intermediate hosts and raw meat reduces the risk of infection and subsequent oocyst shedding [8, 4]. Vaccination of cats with live-attenuated or gene-edited vaccines could reduce environmental contamination by preventing oocyst shedding [26, 27]. Environmental management, including proper disposal of cat feces and protection of water sources from contamination, is critical [6]. In livestock, biosecurity measures such as controlling cat populations on farms and preventing feed contamination reduce the risk of infection in food animals [2, 13]. Serological monitoring of sentinel species, such as pigs and goats, can indicate the level of environmental contamination [2, 13]. Molecular detection of T. gondii in aborted fetuses provides evidence of vertical transmission and can guide management decisions in breeding operations [19, 20]. Public health education campaigns should target pregnant women, veterinary professionals, and the general public to improve knowledge of transmission routes and preventive practices [21, 29, 30].

References

[1] Alrubaye HS, Reilly SM, da Silva R et al. A single-cell atlas of Toxoplasma sexual development in the feline intestinal tract. Nat Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42020723/

[2] Muhammad AS, Kudi AC, Mohammed A et al. Public health significance of prevalence and risk factors associated with Toxoplasma gondii infection in goats sampled from two quarantine facilities and an institutional farm in Maiduguri metropolis, Borno state, Nigeria. Sci Rep. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42020619/

[3] Sena F, Hakimi M-A, Francia ME. Proliferating toward sex: characterization of cell division of Toxoplasma gondii's pre-sexual stages. mBio. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42153709/

[4] Alkhatatbeh SK, Lafi SQ, Hammad HB et al. The first seroprevalence and molecular detection of toxoplasmosis infecting cats in Jordan with associated risk factors. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41741047/

[5] Kengradomkij C, Chimnoi W, Kamyingkird K et al. PCR detection of Toxoplasma gondii DNA in fecal samples from stray cats in Bangkok Metropolitan, Thailand. Food Waterborne Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42094705/

[6] Eyre MT, Wang JY, Carneiro IO et al. Social marginalisation, environmental degradation and Toxoplasma gondii exposure in urban informal settlements in Brazil. PLoS Negl Trop Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42330015/

[7] Zhai B, Bao B, Xie SC et al. Dynamic landscape of microRNA expression in the feline small intestine during Toxoplasma gondii infection. Parasit Vectors. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41965856/

[8] Elsohaby I, Zubair M, Baqar Z et al. Seroprevalence of Toxoplasma gondii and associated demographic factors in privately-owned dogs, cats, and community cats in Hong Kong. BMC Vet Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42135800/

[9] Hanedan B, Taş BZ, Yıldırım E et al. Investigation of Toxoplasma gondii seroprevalence and associated risk factors in dairy cattle in the Eastern Anatolia region of Türkiye. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41819961/

[10] Artiaga-Silva GL, de Lima Ruy Dias ÁF, Carvalho MR et al. High Seroprevalence Rates of Toxoplasma gondii and Neospora caninum in Dogs in the Pantanal Region of Mato Grosso, Brazil. Acta Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41843222/

[11] Aziz KJ, Mikaeelb FB, Nasrullah OJ et al. Seroepidemiological investigation of Toxoplasma gondi and Neospora caninum in local Deers in Erbil, Iraq. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42034957/

[12] Biswas PK, Aryal D, Tarak AN et al. Genotype distribution and risk factors of Toxoplasma gondii infection in animals of Trishal, Bangladesh. PLoS One. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41528989/

[13] Marín-García PJ, Ballesteros-García O, Martínez-Sáez L et al. Low seroprevalence of Toxoplasma gondii in pig farms (Sus scrofa domesticus) of eastern Spain in intensive farms with control of animal entry. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41741032/

[14] Doyle E, Walker J. Diagnosis of pyogranulomatous and neutrophilic lymphadenitis in 72 cats presenting to a referral hospital: with a focus on nine cats with steroid-responsive lymphadenitis. J Feline Med Surg. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41527158/

[15] Murata FHA, Barboza JP, de Souza CAG et al. Investigation of Toxoplasma gondii in reproductive tissues of companion animals from a municipal neutering program. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41651631/

[16] Askaryanzardak A, Kakkassery V, Tartaglione Gracia GP et al. [Ocular toxoplasmosis in adults : Refresher course]. Ophthalmologie. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41603939/

[17] Loeb J. Thrill seekers: how parasites change host behaviour. Vet Rec. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41481062/

[18] Mihaljević D, Sitaš Z, Hanulak J et al. Cerebral Toxoplasmosis in a Renal Transplant Recipient-A Rare Complication. Life (Basel). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41900989/

[19] Pinto GOA, Silva RAD, Oliveira PRF et al. Molecular detection of Toxoplasma gondii in an aborted equine fetus and serological evidence of infection in mares enrolled in embryo transfer programs in Brazil. J Equine Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42252005/

[20] Ait Issad N, Mohamed Cherif A, Mebkhout F et al. First report of molecular and histopathological detection of Toxoplasma gondii in aborted fetal goat myocardium in Algeria with associated risk factors. Parasitol Int. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41864556/

[21] de Velasco-Reyes I, Torres-García SE, Hernández-Rangel JJ et al. Seroprevalence of Toxoplasma gondii Infection in Veterinary Medicine Professionals and Students in Aguascalientes, Mexico. Epidemiologia (Basel). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42201205/

[22] Mu X, Chen C, Pu X et al. Development and Field Validation of a Double-Antigen Sandwich Colloidal Gold Immunochromatographic Strip for Detection of Toxoplasma gondii Antibodies in Multiple Host Species. Transbound Emerg Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42253330/

[23] Chen XX, Sun H, Liang Y et al. Development of a SAG1-based colloidal gold immunochromatographic strip for rapid serological detection of swine Toxoplasma gondii. Parasit Vectors. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42169035/

[24] Günay-Esiyok Ö, Koçkaya ES, Yılmaz R et al. The Potential of MIC17A both as an Entero-epithelial and Chronic Stage Marker for Detection of Feline Toxoplasmosis. Curr Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41874672/

[25] Li YY, Bai SY, Yu HQ et al. Development and evaluation of an antisense PCR assay for Toxoplasma gondii detection in domestic cats. Vet Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41724116/

[26] Sang X, Zhang H, Zhang Y et al. Gene-edited live-attenuated vaccines against Toxoplasma gondii: recent advances and future frontiers. Parasit Vectors. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42252477/

[27] Qadeer A, Tharwat M, Khan MZ et al. Advances and Translational Challenges in Toxoplasma gondii Vaccine Development: From Antigen Discovery to mRNA and One Health Strategies. Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42188907/

[28] Gharbi M, Yera H, Dupouy-Camet J. [The cat, the women and the toxoplasma: What advice should be given to a pregnant woman who is seronegative for toxoplasmosis and owns a cat?]. Gynecol Obstet Fertil Senol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41628830/

[29] Henriette BA, Jémima EK, Jean-Sébastien MA et al. First report of knowledge and practices towards toxoplasmosis among pregnant women in primary care in Abidjan, Côte d'Ivoire. Trop Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42199683/

[30] Chalabi KN, Jabar Bakr E. Toxoplasmosis - knowledge among university students in Erbil, Iraq: a cross-sectional study. Int J Environ Health Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41873025/

[31] Karacali B, Mor N. Investigation of anti-Toxoplasma gondii antibody seropositivity and possible risk factors in women with abortion or stillbirth history in Kars, Turkey. Afr J Reprod Health. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42202767/

[32] Spada E, Tattarletti G, Proverbio D et al. The AB Blood Group System Phenotype Does Not Play a Role in Toxoplasma gondii Infection in Cats. Pathogens. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41471183/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[33] Orish VN, Tetteh RE, Adzah D et al. Toxoplasma gondii seropositivity among patients with sickle cell disease: Prevalence and association with blood transfusion history. PLoS One. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41931585/

[34] Jesuthasan J, Merritt K, Solmi F et al. The association between childhood Toxoplasma gondii, psychotic experiences and grey matter volume: A population-based cohort study. Schizophr Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41643571/

[35] Filho SCC, Moron SE, Ferreira RG et al. Risk Factors and Ocular Health Associated with Toxoplasmosis in Quilombola Communities. Microorganisms. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41597614/